| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 21 | 14,591 | -58,544 | -160,143 |
| Depreciation and amortization | 128,985 | 127,408 | 137,841 | 147,748 |
| Other amortization | 11,801 | 11,714 | 11,586 | 12,260 |
| Share-based compensation | 5,422 | 3,352 | 7,233 | 8,774 |
| Amortization of straight-line rent receivable (lessor) | 8,459 | 4,752 | 6,741 | 7,904 |
| Amortization of straight-line rent on operating leases (lessee) | 563 | 788 | 842 | 859 |
| Loss on derivatives | - | -4,301 | - | - |
| Gain on sales of real estate properties and other assets | 10,777 | 135,711 | 116,081 | 58,363 |
| Loss on extinguishment of debt | -21 | -165 | -286 | - |
| Loss on derivatives | - | - | -2,844 | - |
| Impairment of real estate properties and credit loss reserves | -984 | 105,807 | 104,362 | 142,348 |
| Impairment of goodwill | - | 0 | 0 | 0 |
| Equity income from unconsolidated joint ventures | 496 | -634 | 287 | 158 |
| Distributions from unconsolidated joint ventures | 5,281 | 5,028 | 5,658 | 7,272 |
| Non-cash interest from financing and notes receivable | 428 | 425 | 262 | 217 |
| Other assets, including right-of-use-assets | 21,122 | 5,428 | 8,934 | -10,647 |
| Accounts payable and accrued liabilities | -55,537 | 7,480 | -1,942 | 33,797 |
| Other liabilities | -1,414 | 231 | -3,418 | -12,065 |
| Net cash provided by operating activities | 52,877 | 132,339 | 113,753 | 163,215 |
| Acquisitions of real estate | 2,117 | 100 | - | - |
| Development of real estate | 0 | 17 | 4,431 | 4,760 |
| Additional long-lived assets | 61,154 | 86,548 | 88,824 | 85,653 |
| Funding of mortgages and notes receivable | - | 2,473 | 3,228 | 2,799 |
| Investments in unconsolidated joint ventures | 18,637 | 642 | 568 | 126 |
| Proceeds from (investment in) financing receivable | - | - | - | 191 |
| Investment in financing receivable | - | 5 | 497 | - |
| Contributions from redeemable non-controlling interests | - | 0 | 0 | 0 |
| Investment in financing receivable | 1,003 | - | - | - |
| Proceeds from sales of real estate properties and additional long-lived assets | 29,321 | 611,511 | 323,306 | 50,452 |
| Proceeds from insurance recovery | 4,935 | 0 | 0 | 2,000 |
| Proceeds from notes receivable repayments | 1,340 | 4,758 | 323 | 37,979 |
| Net cash used in investing activities | -45,309 | 526,484 | 226,275 | -3,098 |
| Borrowings on unsecured credit facility | 252,000 | 618,000 | 536,000 | 201,000 |
| Repayments on unsecured credit facility | 316,500 | 647,000 | 682,000 | - |
| Net borrowings on commercial paper program | 250,715 | - | - | - |
| Repayment on term loans | 0 | 541,608 | 73,392 | 140 |
| Repayments of notes and bonds payable | 5,500 | 15,333 | 350 | 250,347 |
| Dividends paid | 83,902 | 84,391 | 84,772 | 108,947 |
| Net proceeds from issuance of common stock | - | 0 | 0 | 0 |
| Common stock redemptions | 2,041 | 379 | 2,915 | 498 |
| Common stock repurchases | 99,999 | 0 | 0 | 0 |
| Distributions to non-controlling interest holders | 1,060 | 1,043 | 1,231 | 1,338 |
| Redemption of non-controlling interest | 769 | 157 | 347 | 0 |
| Settlement of interest rate swaps | - | 4,329 | - | - |
| Debt issuance and assumption costs | 425 | 0 | 13,083 | 0 |
| Payments made on finance leases | 24 | -92 | 99 | -89 |
| Net cash used in financing activities | -7,505 | -676,148 | -322,189 | -160,181 |
| Increase (decrease) in cash and cash equivalents | 63 | -17,325 | 17,839 | -64 |
| Cash and cash equivalents at beginning of period | - | 25,722 | - | - |
| Cash and cash equivalents cash at beginning of period | 26,172 | - | - | - |
| Cash and cash equivalents at end of period | 26,235 | 26,172 | - | - |
Healthcare Realty Trust Inc (HR)
Healthcare Realty Trust Inc (HR)